In this issue:
- OVHIPEC-1: 10-year follow-up of HIPEC + CRS vs. CRS alone in epithelial ovarian cancer
- HIPEC + CRS vs. CRS alone in advanced ovarian cancer
- Prognostic factors in small cell carcinoma of the cervix
- Prognostic factors in neuroendocrine cervical carcinoma
- Post-platinum dostarlimab vs. chemotherapy in recurrent/ advanced endometrial cancer
- ENGOT-EN5/GOG-3055/ SIENDO: selinexor in advanced/recurrent endometrial cancer
- Sentinel lymph node sampling vs. full lymph node dissection in endometrial cancer
- STATICE: T-DXd in advanced/recurrent HER2-expressing
- UC US disparities in ovarian cancer clinical trial participation
- Chemotherapy response in low-grade serous ovarian carcinoma
Please login below to download this issue (PDF)